This inventor holds 1 USPTO granted patent and 1 published patent application and 5 EPO patents. Top assignee: St. John's University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Guido Werner Alves: Innovator in Alzheimer's Disease Diagnosis
Introduction
Guido Werner Alves is a notable inventor based in Stavanger, Norway. He has made significant contributions to the field of medical diagnostics, particularly in the area of Alzheimer's disease. His innovative work focuses on the use of circulating serum microRNA biomarkers for the diagnosis of this debilitating condition.
Latest Patents
Guido holds a patent titled "Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis." This patent encompasses biomarkers and methods for identifying, verifying, and confirming circulating serum-based microRNAs. The microRNAs, referred to as PARKmiRs, can effectively differentiate patients suffering from Alzheimer's disease (AD) from non-AD patients. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Guido is affiliated with St. John's University, where he continues to engage in research and development related to his patent. His work is pivotal in enhancing the understanding and diagnosis of Alzheimer's disease, which affects millions worldwide. His dedication to innovation in this field is commendable.
Collaborations
Guido collaborates with esteemed colleagues, including Simon Geir Möller and Ketan Patil. These partnerships foster a collaborative environment that enhances the research and development of new diagnostic methods.
Conclusion
Guido Werner Alves is a pioneering inventor whose work in Alzheimer's disease diagnosis through microRNA biomarkers is making a significant impact. His contributions to medical science are invaluable, and his ongoing research promises to further advance the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
